Piperacetazine (Quide) : a controlled evaluation of the elixir in chronic schizophrenic patients
Gallant, D.M.; Bishop, M.P.
Current Therapeutic Research 12(6): 387-389
1970
ISSN/ISBN: 0011-393X PMID: 4987346 Document Number: 24886
Document emailed within 1 workday
Related Documents
Gallant, D.M.; Bishop, M.P. 1972: Quide vs. Mellaril in chronic schizophrenic patients Current Therapeutic Research 14(1): 10-16Bishop, M.P.; Gallant, D.M. 1970: Loxapine: a controlled evaluation in chronic schizophrenic patients Current Therapeutic Research 12(9): 594-597
Masciocchi, A.; Reitano, S.; Vanini, M.; Cicchetti, V. 1974: Preliminary results of a controlled trial with sulpiride versus chlorimipramine in chronic schizophrenic patients with marked ideo-emotional poverty Rivista di Patologia Nervosa E Mentale 95(1): 47-52
Simhandl, C.; Rogan, M.; Lesch, O.M.; Musalek, M.; Strobl, R. 1984: Value of professional and self evaluation scales in chronic schizophrenic patients Der Nervenarzt 55(7): 371-377
Bralet, M.C.; Yon, V.; Loas, G.; Noisette, C. 2000: Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients L'Encephale 26(6): 32-41
Náhunek, K.; Svestka, J.; Cesková, E.; Rysánek, R. 1979: Clinical comparison of oxyprothepin and clotepine in schizophrenic patients (controlled study) Activitas Nervosa Superior 21(3): 133-135
Moroni, M.; Cavalli, G.; Lodola, E. 1978: Viminol analgesic activity in elderly patients with chronic pain: a controlled evaluation, using self-rating questionnaires International Journal of Clinical Pharmacology and Biopharmacy 16(11): 513-515
Vergara, L.; Amin, M.M.; Ban, T.A. 1977: A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, Ii Psychopharmacology Bulletin 13(3): 17-19
Karniol, I.G.; Portela, W. 1982: Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study Brazilian Journal of Medical and Biological Research 15(6): 389-394
Levine, J.; Schooler, N.R.; Severe, J.; Escobar, J.; Gelenberg, A.; Mandel, M.; Sovner, R.; Steinbook, R. 1980: Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study Advances in Biochemical Psychopharmacology 24: 483-493
Watkins, A.; Wasmann, S.; Dodson, L.; Hayes, M. 2004: An evaluation of the care provided to patients prescribed controlled substances for chronic nonmalignant pain at an academic family medicine center Family Medicine 36(7): 487-489
Simons, F.E.; Pizey, D.M.; Archer, J.W.; Pagtakhan, R.D. 1979: Terbutaline elixir in preschool children with chronic asthma Annals of Allergy 43(5): 275-278
Ralston, J.D.; Abreu, B.E. 1970: Clinical experience with piperacetazine in hospitalized mental patients. a four year study Journal of the Indiana State Medical Association 63(11): 1291-1296
Zlobina, G.P.; Brusov, O.S.; Morozova, M.A.; Beniashvili, A.G. 2009: Platelet peculiarities in chronic schizophrenic patients Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(10): 47-50
Gillin, J.C.; Kaplan, J.A.; Wyatt, R.J. 1976: Clinical effects of tryptophan in chronic schizophrenic patients Biological Psychiatry 11(5): 635-639
Huang, C.Z.; Weng, C.Y.; Huang, H.L.; Young, S.S.; Chang, J.F.; Lee, G.H. 1989: A study of chronic schizophrenic patients on the attention tests Gaoxiong Yi Xue Ke Xue Za Zhi 5(9): 482-492
Wysokiński, A. 2017: Serum folate and homocysteine in chronic schizophrenic patients Psychiatria Danubina 29(1): 92
Hanihara, T.; Amagai, I.; Hagimoto, H.; Makimoto, Y. 1997: Hypouricemia in chronic schizophrenic patients with polydipsia and hyponatremia Journal of Clinical Psychiatry 58(6): 256-260
Igarashi, T.; Nagata, O.; Iwakiri, H.; Ikeda, M.; Ozaki, M. 2009: Evaluation of target-controlled infusion for propofol in patients with chronic renal failure undergoing living-related renal transplantation Masui. Japanese Journal of Anesthesiology 58(9): 1143-1148
Gallant, D.M.; Bishop, G.; Steel, C.A.; Bishop, M.P. 1973: Loxapine: a six-month evaluation in severely ill schizophrenic patients Current Therapeutic Research 15(4): 205-209